Repro Med Sys Inc (REPR) 0.3901 $REPR Repro Med
Post# of 273242
Posted On: 09/22/2016 7:04:46 PM
Repro Med Sys Inc (REPR) 0.3901 $REPR
Repro Med Systems, Inc. Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors
PR Newswire - Wed May 18, 4:29PM CDT
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced its financial results for the fourth quarter and fiscal year ended February 29, 2016.
Repro Med Systems Announces Share Buyback
ACCESSWIRE - Wed Sep 30, 1:57PM CDT
CHESTER, NY / ACCESSWIRE / September 30, 2015 / REPRO MED SYSTEMS, INC. (OTCQX: REPR) announced today that its Board of Directors has authorized a stock repurchase program pursuant to which the Company will make open market purchases of up to 1,000,000 shares of the Company's Outstanding Common Stock. The purchases will be made through a broker to be designated by the Company with price, timing and volume restrictions based on average daily trading volume, consistent with the safe harbor rules of the Securities and Exchange Commission for such repurchases.
Repro Med Systems, Inc. Posts Strong Revenue Growth and Productivity Gains
ACCESSWIRE - Wed Sep 30, 12:14PM CDT
CHESTER, NY / ACCESSWIRE / September 30, 2015 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced that its second quarter net revenues for fiscal 2016 increased 26.4% over the previous year's Q2, led by the Company's sales of proprietary infusion products. The Company's current fiscal year ends February 28, 2016.
Repro Med Systems, Inc. Qualifies To Trade On OTCQX Market
ACCESSWIRE - Fri Sep 18, 6:31AM CDT
CHESTER, NY / ACCESSWIRE / September 18, 2015 / Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR), a manufacturer of medical devices for the ambulatory (home and institution) infusion market, has qualified to trade on the OTCQX(R) Best Market. Repro Med begins trading today on OTCQX under the symbol "REPR." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
OTC Markets Group Welcomes Repro Med Systems to OTCQX
PR Newswire - Fri Sep 18, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Repro Med Systems, Inc. (OTCQX: REPR), a manufacturer of medical devices for the ambulatory infusion market, has qualified to trade on the OTCQX® Best Market.
Repro Med Systems, Inc. (REPR) Announces Appointment of New CFO
ACCESSWIRE - Tue Jan 20, 6:04AM CST
CHESTER, NY / ACCESSWIRE / January 20, 2015 / Repro-Med Systems, Inc. dba RMS Medical Products (OTCQB:REPR) today announced the appointment of Karen Fisher who will serve as Chief Financial Officer of RMS effective January 28th, 2015.
NYT: 12.42 (+0.13)
Repro Med Systems, Inc. (Repr) Announces Strong Results for Third Quarter Ended November 30, 2014
ACCESSWIRE - Tue Dec 23, 11:14AM CST
CHESTER, NY / ACCESSWIRE / December 23, 2014 / Repro Med Systems, Inc. dba RMS Medical Products (OTC stock symbol REPR) today announced that its year-to-date net revenues for fiscal year 2015 are up 28.6% compared with last year, led by its line of home infusion products, while third quarter net revenues for fiscal 2015 increased 21.8% from fiscal 2014. The company's current fiscal year ends February 28, 2015.
Repro Med Systems, Inc. Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors
PR Newswire - Wed May 18, 4:29PM CDT
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced its financial results for the fourth quarter and fiscal year ended February 29, 2016.
Repro Med Systems Announces Share Buyback
ACCESSWIRE - Wed Sep 30, 1:57PM CDT
CHESTER, NY / ACCESSWIRE / September 30, 2015 / REPRO MED SYSTEMS, INC. (OTCQX: REPR) announced today that its Board of Directors has authorized a stock repurchase program pursuant to which the Company will make open market purchases of up to 1,000,000 shares of the Company's Outstanding Common Stock. The purchases will be made through a broker to be designated by the Company with price, timing and volume restrictions based on average daily trading volume, consistent with the safe harbor rules of the Securities and Exchange Commission for such repurchases.
Repro Med Systems, Inc. Posts Strong Revenue Growth and Productivity Gains
ACCESSWIRE - Wed Sep 30, 12:14PM CDT
CHESTER, NY / ACCESSWIRE / September 30, 2015 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced that its second quarter net revenues for fiscal 2016 increased 26.4% over the previous year's Q2, led by the Company's sales of proprietary infusion products. The Company's current fiscal year ends February 28, 2016.
Repro Med Systems, Inc. Qualifies To Trade On OTCQX Market
ACCESSWIRE - Fri Sep 18, 6:31AM CDT
CHESTER, NY / ACCESSWIRE / September 18, 2015 / Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR), a manufacturer of medical devices for the ambulatory (home and institution) infusion market, has qualified to trade on the OTCQX(R) Best Market. Repro Med begins trading today on OTCQX under the symbol "REPR." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
OTC Markets Group Welcomes Repro Med Systems to OTCQX
PR Newswire - Fri Sep 18, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Repro Med Systems, Inc. (OTCQX: REPR), a manufacturer of medical devices for the ambulatory infusion market, has qualified to trade on the OTCQX® Best Market.
Repro Med Systems, Inc. (REPR) Announces Appointment of New CFO
ACCESSWIRE - Tue Jan 20, 6:04AM CST
CHESTER, NY / ACCESSWIRE / January 20, 2015 / Repro-Med Systems, Inc. dba RMS Medical Products (OTCQB:REPR) today announced the appointment of Karen Fisher who will serve as Chief Financial Officer of RMS effective January 28th, 2015.
NYT: 12.42 (+0.13)
Repro Med Systems, Inc. (Repr) Announces Strong Results for Third Quarter Ended November 30, 2014
ACCESSWIRE - Tue Dec 23, 11:14AM CST
CHESTER, NY / ACCESSWIRE / December 23, 2014 / Repro Med Systems, Inc. dba RMS Medical Products (OTC stock symbol REPR) today announced that its year-to-date net revenues for fiscal year 2015 are up 28.6% compared with last year, led by its line of home infusion products, while third quarter net revenues for fiscal 2015 increased 21.8% from fiscal 2014. The company's current fiscal year ends February 28, 2015.
(0)
(0)Scroll down for more posts ▼